References

10.3322/caac.21387

10.3322/caac.21387 · External reference

Update on immune checkpoint inhibitors in gynecological cancers

10.3802/jgo.2017.28.e20 · 2016 · External reference

Tumor evolution and chemoresistance in ovarian cancer

10.1038/s41698-018-0063-0 · 2018 · External reference

Inflammation and ovarian cancer

10.1016/j.cyto.2012.01.015 · 2012 · External reference

10.18632/oncotarget.14021

10.18632/oncotarget.14021 · External reference

10.1371/journal.pmed.1001789

10.1371/journal.pmed.1001789 · External reference

10.1007/s00404-017-4292-1

10.1007/s00404-017-4292-1 · External reference

10.1158/1078-0432.ccr-17-1159

10.1158/1078-0432.ccr-17-1159 · External reference

10.1038/nature14410

10.1038/nature14410 · External reference

10.1158/1078-0432.ccr-08-0196

10.1158/1078-0432.ccr-08-0196 · External reference

Immune cell profiling in cancer: molecular approaches to cell-specific identification

10.1038/s41698-017-0031-0 · 2017 · External reference

10.1038/nm.3909

10.1038/nm.3909 · External reference

10.1016/s0140-6736(18)30789-x

10.1016/s0140-6736(18)30789-x · External reference

Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference

10.1172/jci200422716 · 2004 · External reference

10.1016/j.bbamcr.2014.12.039

10.1016/j.bbamcr.2014.12.039 · External reference

10.1038/nrc2875

10.1038/nrc2875 · External reference

10.3390/ijms15034356

10.3390/ijms15034356 · External reference

10.1093/jb/mvs090

10.1093/jb/mvs090 · External reference

10.1080/14728222.2017.1332180

10.1080/14728222.2017.1332180 · External reference

10.1038/nrd4099

10.1038/nrd4099 · External reference

Sphingosine-1-phosphate signaling and its role in disease

10.1016/j.tcb.2011.09.003 · 2011 · External reference

10.1007/s10555-011-9304-1

10.1007/s10555-011-9304-1 · External reference

10.1016/s0960-9822(00)00834-4

10.1016/s0960-9822(00)00834-4 · External reference

10.1038/sj.leu.2404023

10.1038/sj.leu.2404023 · External reference

10.1182/blood.v95.9.2897.009k14_2897_2904

10.1182/blood.v95.9.2897.009k14_2897_2904 · External reference

Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells

10.1111/j.1471-4159.2006.04295.x · 2007 · External reference

10.1242/jcs.112.3.415

10.1242/jcs.112.3.415 · External reference

10.1194/jlr.r046300

10.1194/jlr.r046300 · External reference

10.1182/blood-2016-10-743757

10.1182/blood-2016-10-743757 · External reference

10.1074/jbc.m404432200

10.1074/jbc.m404432200 · External reference

10.1182/blood-2007-11-125203

10.1182/blood-2007-11-125203 · External reference

Emerging role of sphingosine-1-phosphate in inflammation, cancer, and lymphangiogenesis

10.3390/biom3030408 · 2013 · External reference

Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach

10.18632/oncotarget.7947 · 2016 · External reference

10.1021/cr200273u

10.1021/cr200273u · External reference

10.1016/j.febslet.2007.05.069

10.1016/j.febslet.2007.05.069 · External reference

Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells

10.1038/onc.2013.303 · 2014 · External reference

10.1371/journal.pbio.1001966

10.1371/journal.pbio.1001966 · External reference

Coming of age for autotaxin and lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation

2018 · External reference

Lysophosphatidate signaling: the tumor microenvironment's new nemesis

10.1016/j.trecan.2017.09.004 · 2017 · External reference

Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses

10.1016/j.cellsig.2006.09.004 · 2007 · External reference

Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition

10.1136/thoraxjnl-2011-200026 · 2012 · External reference

10.1016/j.febslet.2004.10.024

10.1016/j.febslet.2004.10.024 · External reference

10.1083/jcb.200506033

10.1083/jcb.200506033 · External reference

10.1096/fj.05-4810fje

10.1096/fj.05-4810fje · External reference

Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling

10.1194/jlr.r800008-jlr200 · 2008 · External reference

Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-beta in human bronchial epithelial cells

10.1074/jbc.m302896200 · 2003 · External reference

10.2217/fon.10.116

10.2217/fon.10.116 · External reference

10.18632/oncotarget.7145

10.18632/oncotarget.7145 · External reference

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer

10.1186/s12864-016-3001-y · 2016 · External reference

10.1007/978-3-319-92967-5_18

10.1007/978-3-319-92967-5_18 · 2018 · External reference

Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD

10.1097/igc.0b013e31827de6b9 · 2013 · External reference

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium

10.1016/j.ejca.2013.09.011 · 2014 · External reference

10.1371/journal.pone.0025611

10.1371/journal.pone.0025611 · External reference

CD1 expression on antigen-presenting cells

2007 · External reference

10.1371/journal.pone.0099008

10.1371/journal.pone.0099008 · External reference

mice: multivariate imputation by chained equations in R

2011 · External reference

10.18637/jss.v039.i05

10.18637/jss.v039.i05 · External reference

10.1002/sim.4154

10.1002/sim.4154 · External reference

Predictive accuracy and explained variation in cox regression

10.1111/j.0006-341x.2000.00249.x · 2000 · External reference

10.1093/bib/bbq085

10.1093/bib/bbq085 · External reference

REporting recommendations for tumour MARKer prognostic studies (REMARK)

10.1016/j.ejca.2005.03.032 · 2005 · External reference

Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes

10.1155/2008/420747 · 2008 · External reference

10.1002/jcb.10537

10.1002/jcb.10537 · External reference

10.1038/ncomms3126

10.1038/ncomms3126 · External reference

10.1111/j.1365-3083.2008.02091.x

10.1111/j.1365-3083.2008.02091.x · External reference

Mammalian Lass6 and its related family members regulate synthesis of specific ceramides

10.1042/bj20050291 · 2005 · External reference

10.1074/jbc.m707386200

10.1074/jbc.m707386200 · External reference

Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the tram-lag-CLN8 (TLC) domain

10.1074/jbc.m111.280271 · 2012 · External reference

10.1016/j.plipres.2011.11.001

10.1016/j.plipres.2011.11.001 · External reference

Tetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate

10.1194/jlr.m065086 · 2016 · External reference

Plasma levels of lysophosphatidic acid in ovarian cancer versus controls: a meta-analysis

10.1186/s12944-015-0071-9 · 2015 · External reference

Lysophosphatidic acid signaling in ovarian cancer

10.3109/10799893.2015.1026444 · 2015 · External reference

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo

10.7555/jbr.30.20150058 · 2016 · External reference

10.1016/j.neo.2015.09.003

10.1016/j.neo.2015.09.003 · External reference

10.1002/stem.2279

10.1002/stem.2279 · External reference

Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression

10.1096/fj.15-274480 · 2015 · External reference

Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer

10.1530/erc-15-0045 · 2015 · External reference

Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice

10.1194/jlr.m053462 · 2014 · External reference

S1PR4 Signaling attenuates ILT 7 internalization to limit IFN-alpha production by human Plasmacytoid dendritic cells

10.4049/jimmunol.1403168 · 2016 · External reference

Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits

10.1038/ng.3607 · 2016 · External reference

10.1016/j.bmcl.2016.11.050

10.1016/j.bmcl.2016.11.050 · External reference

Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists

10.1016/j.bmcl.2004.07.030 · 2004 · External reference

10.1038/labinvest.2016.116

10.1038/labinvest.2016.116 · External reference

10.1007/s00018-011-0686-6

10.1007/s00018-011-0686-6 · External reference

Sphingomyelinase treatment induces ATP-independent endocytosis

10.1083/jcb.140.1.39 · 1998 · External reference

10.1016/j.cellsig.2009.01.026

10.1016/j.cellsig.2009.01.026 · External reference

The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation

10.2174/156652410791608225 · 2010 · External reference

(n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells

10.1093/jn/137.3.548 · 2007 · External reference

10.1111/j.1462-5822.2008.01169.x

10.1111/j.1462-5822.2008.01169.x · External reference

Secretory sphingomyelinase in health and disease

10.1515/hsz-2015-0109 · 2015 · External reference

10.1073/pnas.95.25.14863

10.1073/pnas.95.25.14863 · External reference